Signaling effectors underlying pathologic growth and remodeling of the heart
Open Access
- 2 January 2013
- journal article
- review article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 123 (1), 37-45
- https://doi.org/10.1172/jci62839
Abstract
Cardiovascular disease is the number one cause of mortality in the Western world. The heart responds to many cardiopathological conditions with hypertrophic growth by enlarging individual myocytes to augment cardiac pump function and decrease ventricular wall tension. Initially, such cardiac hypertrophic growth is often compensatory, but as time progresses these changes become maladaptive. Cardiac hypertrophy is the strongest predictor for the development of heart failure, arrhythmia, and sudden death. Here we discuss therapeutic avenues emerging from molecular and genetic studies of cardiovascular disease in animal models. The majority of these are based on intracellular signaling pathways considered central to pathologic cardiac remodeling and hypertrophy, which then leads to heart failure. We focus our discussion on selected therapeutic targets that have more recently emerged and have a tangible translational potential given the available pharmacologic agents that could be readily evaluated in human clinical trials.Keywords
This publication has 143 references indexed in Scilit:
- CaMKII in myocardial hypertrophy and heart failureJournal of Molecular and Cellular Cardiology, 2011
- The p38 mitogen-activated protein kinase pathway—A potential target for intervention in infarction, hypertrophy, and heart failureJournal of Molecular and Cellular Cardiology, 2011
- Protein kinase Cα as a heart failure therapeutic targetJournal of Molecular and Cellular Cardiology, 2011
- Therapeutic potential of β-arrestin- and G protein-biased agonistsTrends in Molecular Medicine, 2011
- Rho-Kinase in Development and Heart Failure: Insights From Genetic ModelsPediatric Cardiology, 2011
- C/EBPβ Controls Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac RemodelingCell, 2010
- Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation: Novel mechanism of cardiac stress modulation by PDE5 inhibitionJournal of Molecular and Cellular Cardiology, 2010
- Protein kinase C α and ε phosphorylation of troponin and myosin binding protein C reduce Ca2+ sensitivity in human myocardiumBasic Research in Cardiology, 2009
- Sildenafil Stops Progressive Chamber, Cellular, and Molecular Remodeling and Improves Calcium Handling and Function in Hearts With Pre-Existing Advanced Hypertrophy Caused by Pressure OverloadJournal of the American College of Cardiology, 2009
- A Dynamic Pathway for Calcium-Independent Activation of CaMKII by Methionine OxidationCell, 2008